Trials / Unknown
UnknownNCT01287286
Cancers Treated With Combination of Antrodia Cinnamomea and Chemotherapy
Cancers Treated With Combination of Antrodia Cinnamomea and Chemotherapy- a Double Blinded, Randomized, Placebo-controlled Trial
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- Sponsor
- Chang Gung Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate if food supplements,Antrodia cinnamomea, could minimize the gastrointestinal symptom of cancer patients with chemotherapy.
Detailed description
In our unpublished report shows that patients who took Antrodia Cinnamomea compound of 15 milliliters liquid twice in a day, might help white blood cells, red blood cells and hemoglobin increase after 2 months; liver glutamic pyruvic transaminase(GPT) index mitigation, P \<0.05 difference statistically; In addition, liver glutamate oxaloacetate transaminase(GOT) and biochemical index of renal function had no abnormal data statistically. However, cancer patients with gastrointestinal disorders after chemotherapy is known to be a common side effect, we seek to investigate if Antrodia Cinnamomea improves the function of gastrointestinal system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | AC-Can | Antrodia cinnamomea compounds of 15 milliliters liquid per pack, oral post meal, twice in a day for 30 days |
| DIETARY_SUPPLEMENT | placebo | Placebo of 15 milliliters liquid per pack, oral post meal, twice in a day for 30 days |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2011-04-01
- Completion
- 2012-05-01
- First posted
- 2011-02-01
- Last updated
- 2011-02-08
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01287286. Inclusion in this directory is not an endorsement.